Have there been cases where DecisionDx-SCC reclassified a tumor you initially considered low or intermediate risk? How did that change management?

Featuring David Cotter, MD, PhD | Assistant Clinical Professor UNLV School of Medicine Las Vegas Dermatology Las Vegas, NV | Published March 06, 2026